In the published article, there was an error in affiliation 1. Instead of “Division of Life Sciences and Medicine, Department of Pharmacy, Anhui Provincial Cancer Hospital, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China”, it should be “Department of Pharmacy, Anhui Provincial Cancer Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China”.
In the published article, there was an error in affiliation 3. Instead of “Division of Life Sciences and Medicine, Department of Pharmacy, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China”, it should be “Department of Pharmacy, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
epigenetic regulation, miRNAs, inflammatory, cellular signal transduction, therapeutic target, diabetic nephropathy, immune
Citation
Zhou H, Ni W-J, Meng X-M and Tang L-Q (2022) Corrigendum: MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy. Front. Cell Dev. Biol. 10:875280. doi: 10.3389/fcell.2022.875280
Received
14 February 2022
Accepted
15 February 2022
Published
01 March 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
10 - 2022
Updates
Copyright
© 2022 Zhou, Ni, Meng and Tang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wei-Jian Ni, niweijian@ustc.edu.cn; Xiao-Ming Meng, mengxiaoming@ahmu.edu.cn; Li-Qin Tang, tangliqin@ustc.edu.cn
This article was submitted to Epigenomics and Epigenetics, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.